Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.

Authors:
Chen H; Peng J; Wang T; Wen J; Chen S and 2 more

Journal:
Biochem Pharmacol

Publication Year: 2022

DOI:
10.1016/j.bcp.2022.115370

PMCID:
PMC9721294

PMID:
36481346

Journal Information

Full Title: Biochem Pharmacol

Abbreviation: Biochem Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China (82000462) (Y.Z.), Research Grants Council of Hong Kong (SRFS2021-4S04) (Y.H.), and Guangdong Basic and Applied Basic Research Foundation (2021B1515020005) (S.C.). Hongyin Chen: Investigation, Writing – original draft, Visualization. Jiangyun Peng: Investigation, Writing – original draft. Tengyao Wang: Investigation, Writing – original draft. Jielu Wen: Investigation, Writing – original draft. Sifan Chen: Investigation, Supervision, Funding acquisition, Writing – review & editing. Yu Huang: Supervision, Funding acquisition, Writing – review & editing. Yang Zhang: Conceptualization, Supervision, Funding acquisition, Writing – original draft, Writing – review & editing."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025